U.S. IP Update – May 2026

Sterne Kessler’s U.S. IP Update is a newsletter delivering the latest developments in U.S. intellectual property law, tailored for companies and legal counsel in Korea. Stay informed on key court decisions, policy changes, and trends impacting patents, trademarks, and other IP rights in the United States.

Thank you for your readership. If there are topics that you would like us to cover in a future issue, please contact our editors. Please subscribe to receive future issues.

In This Issue: 

Key Takeaways: AI-Assisted Innovation and Patent Protection in Biotech
Daniel Block and Carla Kim

During this webinar, Sterne Kessler attorneys explored how today’s inventorship framework applies to AI‑assisted biotech innovation and what companies can do now to protect long‑term value. Watch the webinar on demand to learn more about how AI-assisted innovation may affect your IP strategy.

AI Is Not Your Lawyer: Discovery Risks for Legal and IP Strategy
Kimberlynn Seifert and Joseph Kim 

In the case, United States v. Heppner, Judge Jed S. Rakoff found that a criminal defendant’s use of the public AI platform “Claude” was not protected by the attorney-client privilege or the work-product doctrine. In this article, we analyze the case and provide key takeaways and implications for your own IP strategy.

Key Provisions of the Remedy Act and Their Impact on Hatch‑Waxman Litigation
Anna Phillips, Brooke McLain, and Bridget Moore

Learn how the proposed U.S. legislation known as the REMEDY Act has the potential to change how patent-owning pharmaceutical companies assert their patent portfolio in our recent article.